Senphonix
Senphonix is a MedTech startup dedicated to transforming patient monitoring through intelligent, automated, and continuous vital signs tracking. Their mission is to close the gap between data and action in healthcare, enabling precision, clarity, and compassion for patients, clinicians, and healthcare systems. By leveraging breakthrough wearable technology and secure, cloud-based software, Senphonix aims to reduce clinician burden, improve patient outcomes, and drive efficiency across the continuum of care. The company is headquartered in Minnesota and Arizona, and collaborates with leading academic and healthcare partners to bring next-generation solutions to market.
Industries
N/A
Nr. of Employees
small (1-50)
Senphonix
59 Fourth Street West, Suite 21D, St. Paul, MN 55102
Products
Adhesive-free mesh vitals sleeve (prototype/MVP)
An adhesive-free, breathable mesh sleeve that wirelessly charges and continuously captures clinical-grade biosignals (heart rate, respiration, temperature, movement) and transmits encrypted data to a HIPAA-compliant cloud for EHR integration and alerting.
Adhesive-free mesh vitals sleeve (prototype/MVP)
An adhesive-free, breathable mesh sleeve that wirelessly charges and continuously captures clinical-grade biosignals (heart rate, respiration, temperature, movement) and transmits encrypted data to a HIPAA-compliant cloud for EHR integration and alerting.
Expertise Areas
- Continuous patient monitoring
- Wearable biosensor design
- Cloud-based clinical data platforms
- EHR integration and interoperability
Key Technologies
- Wearable biosensors
- Mesh/skin-like medical textiles
- Wireless power transfer (wireless charging)
- Bluetooth Low Energy (BLE)
Key People
Co-Founder and Co-CEO
Co-Founder and Co-CEO
Clinical Affairs Consultant
Healthcare Policy Consultant
Med Device Technology Consultant
Co-Founder and Co-CEO
Co-Founder and Co-CEO
Clinical Affairs Consultant
Healthcare Policy Consultant
Med Device Technology Consultant
News & Updates
Senphonix holds an exclusive, worldwide license from the University of Arizona to the core intellectual property utilized in its SleeveSense product.
Market research conducted by MarketWise Advising in April 2025 validated a 98% market need/solution match for SleeveSense, with 95% confidence (n=402; +/- 5% error rate).
Senphonix's leadership team has deep experience in bringing breakthrough healthcare technologies to market and scaling them successfully.
Academic paper by Dr. Gutruf and colleagues on biosymbiotic platforms for chronic monitoring.
Academic paper discussing the challenges and opportunities in wearable biosignal monitoring.
Academic paper on electromagnetic design for wearable biosymbiotic devices.
Senphonix holds an exclusive, worldwide license from the University of Arizona to the core intellectual property utilized in its SleeveSense product.
Market research conducted by MarketWise Advising in April 2025 validated a 98% market need/solution match for SleeveSense, with 95% confidence (n=402; +/- 5% error rate).
Senphonix's leadership team has deep experience in bringing breakthrough healthcare technologies to market and scaling them successfully.
Academic paper by Dr. Gutruf and colleagues on biosymbiotic platforms for chronic monitoring.
Academic paper discussing the challenges and opportunities in wearable biosignal monitoring.
Academic paper on electromagnetic design for wearable biosymbiotic devices.